Mealey's (September 17, 2020, 4:02 PM EDT) -- NEW YORK — An investor in a data content and services provider to health care providers filed a shareholder derivative lawsuit against the company's CEO and three of its directors in New York federal court on Aug. 21, alleging that the defendants breached their fiduciary duty by issuing and/or causing the company to falsely represent to the investing public that it had received a purchase order to produce millions of COVID-19 rapid test kits with the ability to produce a total of 48 million test kits over a 23-week period (Josstyn Richter v. Marc S. Schessel, et al., No. 20-6760, S.D. N.Y.)....